Your session is about to expire
← Back to Search
Focused Ultrasound
Transcranial Focused Ultrasound for Depression and Anxiety
N/A
Waitlist Available
Led By Sheldon Jordan, M.D.
Research Sponsored by Neurological Associates of West Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 18 years of age
Failure to remit with 3 anxiolytics
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after final ultrasound (8 weeks from baseline)
Awards & highlights
Summary
This trial will study whether transcranial ultrasound is a safe and effective treatment for patients with depression and anxiety that has not responded to other treatments.
Who is the study for?
This trial is for adults who have tried at least three antidepressants and anxiolytics without improvement, have a diagnosis of Major Depressive Disorder or Generalized/Acute Anxiety Disorder, and score high on anxiety and depression scales.
What is being tested?
The study is testing the use of transcranial focused ultrasound as a treatment. It's an open label study, meaning everyone knows they're getting the treatment, to see if it helps with severe depression and anxiety.
What are the potential side effects?
Since this summary doesn't provide specific side effects of transcranial focused ultrasound, generally such treatments may cause discomfort at the site of application, headache or dizziness during or after treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I have tried 3 different anxiety medications without success.
Select...
I have tried 3 antidepressants without success.
Select...
I have been diagnosed with Major Depressive Disorder.
Select...
I have been diagnosed with Generalized or Acute Anxiety Disorder.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after final ultrasound (8 weeks from baseline)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after final ultrasound (8 weeks from baseline)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Secondary study objectives
Beck Anxiety Inventory
Beck Depression Inventory
Hamilton Anxiety Rating Scale
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
All patients enrolled will receive transcranial focused ultrasound. Target location is dependent on patient condition.
Find a Location
Who is running the clinical trial?
Neurological Associates of West Los AngelesLead Sponsor
25 Previous Clinical Trials
3,860 Total Patients Enrolled
Sheldon Jordan, M.D.Principal InvestigatorNeurological Associates - the Interventional Group
4 Previous Clinical Trials
815 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.You have a score of more than 13 on a test called the Beck Depression Inventory.I have tried 3 different anxiety medications without success.I have tried 3 antidepressants without success.I have been diagnosed with Major Depressive Disorder.I have been diagnosed with Generalized or Acute Anxiety Disorder.You have severe anxiety, as measured by the Beck Anxiety Inventory score being greater than 15.
Research Study Groups:
This trial has the following groups:- Group 1: Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger